🇺🇸 FDA
Patent

US 6407132

Substituted imidazole derivatives and their use as histamine H3 receptor ligands

expired A61PA61P11/06A61P25/08

Quick answer

US patent 6407132 (Substituted imidazole derivatives and their use as histamine H3 receptor ligands) held by The James Black Foundation Limited expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The James Black Foundation Limited
Grant date
Tue Jun 18 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P11/06, A61P25/08, A61P25/24, A61P37/08